)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Innoviva (INVA) investor relations material
Innoviva Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Piper Sandler 37th Annual Healthcare Conference summary2 Dec, 2025
Business overview and strategy
Operates a diversified model with royalty-based respiratory assets, a fast-growing specialty therapeutics business, and a strategic healthcare investment portfolio valued at $500 million.
Royalty business generates about $250 million annually from Breo and Anoro, with strong patent protection into the early 2030s.
Specialty therapeutics (IST) delivers over $100 million in revenue, growing rapidly, driven by differentiated hospital products.
Strategic investments target disruptive healthcare assets with high upside and downside protection.
Maintains flexibility in capital deployment, open to opportunistic royalty acquisitions and synergistic hospital assets.
Specialty therapeutics (IST) growth drivers
Giapreza leads revenue, benefiting from refreshed commercial strategy and new clinical data expanding use cases.
Xacduro addresses significant unmet need in resistant Acinetobacter infections, showing strong launch performance.
Xerava benefits from resistance trends and remains relevant despite being a mature product.
Zevtera, recently launched, targets Staph aureus bacteremia and is expected to ramp as access expands.
All IST products have patent protection into the 2030s, with no near-term exclusivity losses.
Commercial and market access strategy
Hospital launches require navigation of stewardship and P&T committees, but differentiated products ease access.
Zevtera is positioned as an early option for challenging bacteremia cases, with skin and pneumonia indications seen as upside.
Giapreza is increasingly used earlier in ICU shock, with expanding adoption in new patient populations.
Zoliflodacin, pending approval, offers oral therapy for resistant gonorrhea, with commercialization likely to leverage guidelines and a lean sales model.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Innoviva earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Innoviva Inc. is a biopharmaceutical company focused on managing and developing royalty portfolios. The company's primary business involves the commercialization of its portfolio of royalties, primarily derived from partnerships with pharmaceutical companies. Innoviva's portfolio includes interests in respiratory medicines and other therapeutic areas, where it receives royalties from the sale of these products. The company is involved in actively managing its royalty portfolio and exploring potential acquisitions or partnerships to expand its interests in healthcare assets. The company is headquartered in Burlingame, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage